nodes	percent_of_prediction	percent_of_DWPC	metapath
Etidronic acid—Paget's disease of bone—osteoporosis	0.153	1	CtDrD
Etidronic acid—Diphosphonates—Ibandronate—osteoporosis	0.0864	0.305	CiPCiCtD
Etidronic acid—PTPRS—Alendronate—osteoporosis	0.0838	0.58	CbGbCtD
Etidronic acid—Diphosphonates—Risedronate—osteoporosis	0.0655	0.231	CiPCiCtD
Etidronic acid—Diphosphonates—Pamidronate—osteoporosis	0.0655	0.231	CiPCiCtD
Etidronic acid—Diphosphonates—Alendronate—osteoporosis	0.0655	0.231	CiPCiCtD
Etidronic acid—Ibandronate—osteoporosis	0.0627	0.268	CrCtD
Etidronic acid—ATP6V1A—Alendronate—osteoporosis	0.0606	0.419	CbGbCtD
Etidronic acid—Zoledronate—osteoporosis	0.0442	0.189	CrCtD
Etidronic acid—Risedronate—osteoporosis	0.0442	0.189	CrCtD
Etidronic acid—Alendronate—osteoporosis	0.0415	0.177	CrCtD
Etidronic acid—Pamidronate—osteoporosis	0.0415	0.177	CrCtD
Etidronic acid—Risedronate—Ibandronate—osteoporosis	0.00887	0.0573	CrCrCtD
Etidronic acid—Zoledronate—Ibandronate—osteoporosis	0.00887	0.0573	CrCrCtD
Etidronic acid—Clodronate—Zoledronate—osteoporosis	0.00864	0.0558	CrCrCtD
Etidronic acid—Clodronate—Alendronate—osteoporosis	0.00813	0.0525	CrCrCtD
Etidronic acid—Clodronate—Pamidronate—osteoporosis	0.00813	0.0525	CrCrCtD
Etidronic acid—Alendronate—Ibandronate—osteoporosis	0.00784	0.0506	CrCrCtD
Etidronic acid—Pamidronate—Ibandronate—osteoporosis	0.00784	0.0506	CrCrCtD
Etidronic acid—Ibandronate—Zoledronate—osteoporosis	0.00723	0.0467	CrCrCtD
Etidronic acid—Ibandronate—Risedronate—osteoporosis	0.00723	0.0467	CrCrCtD
Etidronic acid—Ibandronate—Pamidronate—osteoporosis	0.0068	0.0439	CrCrCtD
Etidronic acid—Ibandronate—Alendronate—osteoporosis	0.0068	0.0439	CrCrCtD
Etidronic acid—Zoledronate—Risedronate—osteoporosis	0.00625	0.0404	CrCrCtD
Etidronic acid—Risedronate—Zoledronate—osteoporosis	0.00625	0.0404	CrCrCtD
Etidronic acid—Zoledronate—Alendronate—osteoporosis	0.00587	0.0379	CrCrCtD
Etidronic acid—Zoledronate—Pamidronate—osteoporosis	0.00587	0.0379	CrCrCtD
Etidronic acid—Risedronate—Alendronate—osteoporosis	0.00587	0.0379	CrCrCtD
Etidronic acid—Risedronate—Pamidronate—osteoporosis	0.00587	0.0379	CrCrCtD
Etidronic acid—Pamidronate—Risedronate—osteoporosis	0.00552	0.0357	CrCrCtD
Etidronic acid—Alendronate—Zoledronate—osteoporosis	0.00552	0.0357	CrCrCtD
Etidronic acid—Pamidronate—Zoledronate—osteoporosis	0.00552	0.0357	CrCrCtD
Etidronic acid—Alendronate—Risedronate—osteoporosis	0.00552	0.0357	CrCrCtD
Etidronic acid—Pamidronate—Alendronate—osteoporosis	0.00519	0.0335	CrCrCtD
Etidronic acid—Alendronate—Pamidronate—osteoporosis	0.00519	0.0335	CrCrCtD
Etidronic acid—PTPRS—ECM proteoglycans—IBSP—osteoporosis	0.00148	0.244	CbGpPWpGaD
Etidronic acid—ATP6V1A—Latent infection of Homo sapiens with Mycobacterium tuberculosis—LTF—osteoporosis	0.000686	0.113	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—IBSP—osteoporosis	0.000423	0.0697	CbGpPWpGaD
Etidronic acid—Ibandronate—FDPS—osteoporosis	0.000364	0.276	CrCbGaD
Etidronic acid—Pamidronate—FDPS—osteoporosis	0.000318	0.242	CrCbGaD
Etidronic acid—Risedronate—FDPS—osteoporosis	0.000256	0.195	CrCbGaD
Etidronic acid—PTPRS—Extracellular matrix organization—P4HB—osteoporosis	0.000206	0.034	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—COL1A2—osteoporosis	0.000203	0.0334	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—CTSK—osteoporosis	0.000196	0.0323	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—FGA—osteoporosis	0.000179	0.0295	CbGpPWpGaD
Etidronic acid—Alendronate—FDPS—osteoporosis	0.000167	0.127	CrCbGaD
Etidronic acid—PTPRS—Extracellular matrix organization—BMP2—osteoporosis	0.000166	0.0274	CbGpPWpGaD
Etidronic acid—Zoledronate—FDPS—osteoporosis	0.000165	0.126	CrCbGaD
Etidronic acid—PTPRS—Extracellular matrix organization—FGB—osteoporosis	0.000163	0.0268	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—COL1A1—osteoporosis	0.000156	0.0257	CbGpPWpGaD
Etidronic acid—PTPRS—ECM proteoglycans—TGFB1—osteoporosis	0.000155	0.0255	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—KL—osteoporosis	0.000125	0.0207	CbGpPWpGaD
Etidronic acid—PTPRS—Extracellular matrix organization—SPP1—osteoporosis	0.000101	0.0166	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—IRS2—osteoporosis	8.6e-05	0.0142	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—IRS1—osteoporosis	7.51e-05	0.0124	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—IL6R—osteoporosis	7.05e-05	0.0116	CbGpPWpGaD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ANXA2—osteoporosis	6.98e-05	0.0115	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—SOST—osteoporosis	5.94e-05	0.00979	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PKM—osteoporosis	5.94e-05	0.00979	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PGLS—osteoporosis	5.63e-05	0.00928	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—ANTXR2—osteoporosis	5.63e-05	0.00928	CbGpPWpGaD
Etidronic acid—Asthma—Zoledronate—osteoporosis	5.39e-05	0.00227	CcSEcCtD
Etidronic acid—Diarrhoea—Calcium Acetate—osteoporosis	5.38e-05	0.00226	CcSEcCtD
Etidronic acid—Alopecia—Ibandronate—osteoporosis	5.33e-05	0.00224	CcSEcCtD
Etidronic acid—Flatulence—Alendronate—osteoporosis	5.31e-05	0.00223	CcSEcCtD
Etidronic acid—Muscle spasms—Estropipate—osteoporosis	5.26e-05	0.00221	CcSEcCtD
Etidronic acid—Erythema—Ibandronate—osteoporosis	5.25e-05	0.00221	CcSEcCtD
Etidronic acid—Flatulence—Raloxifene—osteoporosis	5.23e-05	0.0022	CcSEcCtD
Etidronic acid—Asthma—Conjugated Estrogens—osteoporosis	5.19e-05	0.00218	CcSEcCtD
Etidronic acid—Muscle spasms—Alendronate—osteoporosis	5.18e-05	0.00218	CcSEcCtD
Etidronic acid—Flatulence—Ibandronate—osteoporosis	5.17e-05	0.00218	CcSEcCtD
Etidronic acid—Erythema—Calcitriol—osteoporosis	5.14e-05	0.00216	CcSEcCtD
Etidronic acid—Pancytopenia—Zoledronate—osteoporosis	5.12e-05	0.00215	CcSEcCtD
Etidronic acid—Amnesia—Estradiol—osteoporosis	5.12e-05	0.00215	CcSEcCtD
Etidronic acid—Muscle spasms—Raloxifene—osteoporosis	5.1e-05	0.00214	CcSEcCtD
Etidronic acid—Muscle spasms—Ibandronate—osteoporosis	5.05e-05	0.00212	CcSEcCtD
Etidronic acid—Angioedema—Estropipate—osteoporosis	5e-05	0.0021	CcSEcCtD
Etidronic acid—Vomiting—Calcium Acetate—osteoporosis	5e-05	0.0021	CcSEcCtD
Etidronic acid—Anaemia—Alendronate—osteoporosis	4.98e-05	0.0021	CcSEcCtD
Etidronic acid—Arthritis—Estradiol—osteoporosis	4.95e-05	0.00208	CcSEcCtD
Etidronic acid—Angioedema—Alendronate—osteoporosis	4.93e-05	0.00207	CcSEcCtD
Etidronic acid—Agranulocytosis—Pamidronate—osteoporosis	4.91e-05	0.00207	CcSEcCtD
Etidronic acid—Anaemia—Ibandronate—osteoporosis	4.85e-05	0.00204	CcSEcCtD
Etidronic acid—Erythema multiforme—Ethinyl Estradiol—osteoporosis	4.82e-05	0.00203	CcSEcCtD
Etidronic acid—Osteoarthritis—Estradiol—osteoporosis	4.81e-05	0.00202	CcSEcCtD
Etidronic acid—Angioedema—Ibandronate—osteoporosis	4.8e-05	0.00202	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—GSN—osteoporosis	4.79e-05	0.00789	CbGpPWpGaD
Etidronic acid—Nausea—Calcium Acetate—osteoporosis	4.67e-05	0.00196	CcSEcCtD
Etidronic acid—Arthralgia—Estropipate—osteoporosis	4.66e-05	0.00196	CcSEcCtD
Etidronic acid—Zoledronate—CA2—osteoporosis	4.56e-05	0.0346	CrCbGaD
Etidronic acid—Neuropathy peripheral—Conjugated Estrogens—osteoporosis	4.54e-05	0.00191	CcSEcCtD
Etidronic acid—Discomfort—Alendronate—osteoporosis	4.54e-05	0.00191	CcSEcCtD
Etidronic acid—Arthralgia—Raloxifene—osteoporosis	4.51e-05	0.0019	CcSEcCtD
Etidronic acid—Alopecia—Ethinyl Estradiol—osteoporosis	4.5e-05	0.00189	CcSEcCtD
Etidronic acid—Agranulocytosis—Zoledronate—osteoporosis	4.49e-05	0.00189	CcSEcCtD
Etidronic acid—Arthralgia—Ibandronate—osteoporosis	4.47e-05	0.00188	CcSEcCtD
Etidronic acid—Infection—Estropipate—osteoporosis	4.44e-05	0.00187	CcSEcCtD
Etidronic acid—PTPRS—Extracellular matrix organization—TGFB1—osteoporosis	4.42e-05	0.00728	CbGpPWpGaD
Etidronic acid—Discomfort—Ibandronate—osteoporosis	4.42e-05	0.00186	CcSEcCtD
Etidronic acid—Infection—Alendronate—osteoporosis	4.37e-05	0.00184	CcSEcCtD
Etidronic acid—Discomfort—Calcitriol—osteoporosis	4.32e-05	0.00182	CcSEcCtD
Etidronic acid—Infection—Raloxifene—osteoporosis	4.3e-05	0.00181	CcSEcCtD
Etidronic acid—Muscle spasms—Ethinyl Estradiol—osteoporosis	4.27e-05	0.00179	CcSEcCtD
Etidronic acid—Flatulence—Risedronate—osteoporosis	4.26e-05	0.00179	CcSEcCtD
Etidronic acid—Infection—Ibandronate—osteoporosis	4.26e-05	0.00179	CcSEcCtD
Etidronic acid—Gastritis—Estradiol—osteoporosis	4.25e-05	0.00179	CcSEcCtD
Etidronic acid—Alopecia—Pamidronate—osteoporosis	4.17e-05	0.00176	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—LRP5—osteoporosis	4.17e-05	0.00686	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SOST—osteoporosis	4.16e-05	0.00685	CbGpPWpGaD
Etidronic acid—Muscle spasms—Risedronate—osteoporosis	4.16e-05	0.00175	CcSEcCtD
Etidronic acid—Asthma—Estradiol—osteoporosis	4.15e-05	0.00175	CcSEcCtD
Etidronic acid—Nausea—Ergocalciferol—osteoporosis	4.13e-05	0.00174	CcSEcCtD
Etidronic acid—Erythema—Pamidronate—osteoporosis	4.11e-05	0.00173	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Estropipate—osteoporosis	4.07e-05	0.00171	CcSEcCtD
Etidronic acid—Angioedema—Ethinyl Estradiol—osteoporosis	4.05e-05	0.0017	CcSEcCtD
Etidronic acid—Paraesthesia—Estropipate—osteoporosis	4.01e-05	0.00169	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Alendronate—osteoporosis	4.01e-05	0.00169	CcSEcCtD
Etidronic acid—Anaemia—Risedronate—osteoporosis	4e-05	0.00168	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—LRP6—osteoporosis	3.98e-05	0.00656	CbGpPWpGaD
Etidronic acid—Muscle spasms—Pamidronate—osteoporosis	3.95e-05	0.00166	CcSEcCtD
Etidronic acid—Angioedema—Risedronate—osteoporosis	3.95e-05	0.00166	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Raloxifene—osteoporosis	3.94e-05	0.00166	CcSEcCtD
Etidronic acid—Dyspepsia—Estropipate—osteoporosis	3.93e-05	0.00165	CcSEcCtD
Etidronic acid—Erythema multiforme—Conjugated Estrogens—osteoporosis	3.93e-05	0.00165	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Ibandronate—osteoporosis	3.9e-05	0.00164	CcSEcCtD
Etidronic acid—Dyspepsia—Alendronate—osteoporosis	3.87e-05	0.00163	CcSEcCtD
Etidronic acid—Paraesthesia—Ibandronate—osteoporosis	3.85e-05	0.00162	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—LTF—osteoporosis	3.83e-05	0.00631	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—RPL24—osteoporosis	3.83e-05	0.00631	CbGpPWpGaD
Etidronic acid—Musculoskeletal discomfort—Calcitriol—osteoporosis	3.82e-05	0.00161	CcSEcCtD
Etidronic acid—Constipation—Estropipate—osteoporosis	3.82e-05	0.00161	CcSEcCtD
Etidronic acid—Alopecia—Zoledronate—osteoporosis	3.81e-05	0.0016	CcSEcCtD
Etidronic acid—Dyspepsia—Raloxifene—osteoporosis	3.81e-05	0.0016	CcSEcCtD
Etidronic acid—Anaemia—Pamidronate—osteoporosis	3.8e-05	0.0016	CcSEcCtD
Etidronic acid—Dyspepsia—Ibandronate—osteoporosis	3.77e-05	0.00159	CcSEcCtD
Etidronic acid—Constipation—Alendronate—osteoporosis	3.76e-05	0.00158	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PTH1R—osteoporosis	3.76e-05	0.0062	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CALCR—osteoporosis	3.76e-05	0.0062	CbGpPWpGaD
Etidronic acid—Angioedema—Pamidronate—osteoporosis	3.76e-05	0.00158	CcSEcCtD
Etidronic acid—Erythema—Zoledronate—osteoporosis	3.76e-05	0.00158	CcSEcCtD
Etidronic acid—Discomfort—Ethinyl Estradiol—osteoporosis	3.73e-05	0.00157	CcSEcCtD
Etidronic acid—Arthralgia—Risedronate—osteoporosis	3.68e-05	0.00155	CcSEcCtD
Etidronic acid—Leukopenia—Pamidronate—osteoporosis	3.68e-05	0.00155	CcSEcCtD
Etidronic acid—Alopecia—Conjugated Estrogens—osteoporosis	3.67e-05	0.00154	CcSEcCtD
Etidronic acid—Constipation—Ibandronate—osteoporosis	3.66e-05	0.00154	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Estropipate—osteoporosis	3.65e-05	0.00154	CcSEcCtD
Etidronic acid—Neuropathy peripheral—Estradiol—osteoporosis	3.63e-05	0.00153	CcSEcCtD
Etidronic acid—Feeling abnormal—Alendronate—osteoporosis	3.63e-05	0.00152	CcSEcCtD
Etidronic acid—Erythema—Conjugated Estrogens—osteoporosis	3.62e-05	0.00152	CcSEcCtD
Etidronic acid—Muscle spasms—Zoledronate—osteoporosis	3.61e-05	0.00152	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Alendronate—osteoporosis	3.6e-05	0.00151	CcSEcCtD
Etidronic acid—Infection—Ethinyl Estradiol—osteoporosis	3.6e-05	0.00151	CcSEcCtD
Etidronic acid—Constipation—Calcitriol—osteoporosis	3.59e-05	0.00151	CcSEcCtD
Etidronic acid—Flatulence—Conjugated Estrogens—osteoporosis	3.56e-05	0.0015	CcSEcCtD
Etidronic acid—Urticaria—Estropipate—osteoporosis	3.55e-05	0.00149	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Raloxifene—osteoporosis	3.54e-05	0.00149	CcSEcCtD
Etidronic acid—Abdominal pain—Estropipate—osteoporosis	3.53e-05	0.00149	CcSEcCtD
Etidronic acid—Feeling abnormal—Ibandronate—osteoporosis	3.53e-05	0.00148	CcSEcCtD
Etidronic acid—Infection—Risedronate—osteoporosis	3.51e-05	0.00148	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Ibandronate—osteoporosis	3.5e-05	0.00147	CcSEcCtD
Etidronic acid—Arthralgia—Pamidronate—osteoporosis	3.5e-05	0.00147	CcSEcCtD
Etidronic acid—Urticaria—Alendronate—osteoporosis	3.5e-05	0.00147	CcSEcCtD
Etidronic acid—Abdominal pain—Alendronate—osteoporosis	3.48e-05	0.00146	CcSEcCtD
Etidronic acid—Muscle spasms—Conjugated Estrogens—osteoporosis	3.48e-05	0.00146	CcSEcCtD
Etidronic acid—Anaemia—Zoledronate—osteoporosis	3.47e-05	0.00146	CcSEcCtD
Etidronic acid—Discomfort—Pamidronate—osteoporosis	3.46e-05	0.00145	CcSEcCtD
Etidronic acid—Angioedema—Zoledronate—osteoporosis	3.43e-05	0.00144	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Calcitriol—osteoporosis	3.43e-05	0.00144	CcSEcCtD
Etidronic acid—Abdominal pain—Raloxifene—osteoporosis	3.42e-05	0.00144	CcSEcCtD
Etidronic acid—Urticaria—Ibandronate—osteoporosis	3.4e-05	0.00143	CcSEcCtD
Etidronic acid—Abdominal pain—Ibandronate—osteoporosis	3.39e-05	0.00142	CcSEcCtD
Etidronic acid—Confusional state—Pamidronate—osteoporosis	3.38e-05	0.00142	CcSEcCtD
Etidronic acid—Leukopenia—Zoledronate—osteoporosis	3.36e-05	0.00141	CcSEcCtD
Etidronic acid—Infection—Pamidronate—osteoporosis	3.33e-05	0.0014	CcSEcCtD
Etidronic acid—Urticaria—Calcitriol—osteoporosis	3.33e-05	0.0014	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—ACP5—osteoporosis	3.32e-05	0.00547	CbGpPWpGaD
Etidronic acid—Abdominal pain—Calcitriol—osteoporosis	3.32e-05	0.00139	CcSEcCtD
Etidronic acid—Angioedema—Conjugated Estrogens—osteoporosis	3.31e-05	0.00139	CcSEcCtD
Etidronic acid—Hypersensitivity—Estropipate—osteoporosis	3.29e-05	0.00138	CcSEcCtD
Etidronic acid—Hypersensitivity—Alendronate—osteoporosis	3.24e-05	0.00136	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Risedronate—osteoporosis	3.22e-05	0.00135	CcSEcCtD
Etidronic acid—Arthralgia—Zoledronate—osteoporosis	3.2e-05	0.00134	CcSEcCtD
Etidronic acid—Paraesthesia—Risedronate—osteoporosis	3.17e-05	0.00133	CcSEcCtD
Etidronic acid—Pruritus—Estropipate—osteoporosis	3.16e-05	0.00133	CcSEcCtD
Etidronic acid—Discomfort—Zoledronate—osteoporosis	3.16e-05	0.00133	CcSEcCtD
Etidronic acid—Hypersensitivity—Ibandronate—osteoporosis	3.16e-05	0.00133	CcSEcCtD
Etidronic acid—Erythema multiforme—Estradiol—osteoporosis	3.14e-05	0.00132	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling by Insulin receptor—IL6—osteoporosis	3.14e-05	0.00518	CbGpPWpGaD
Etidronic acid—Pruritus—Alendronate—osteoporosis	3.11e-05	0.00131	CcSEcCtD
Etidronic acid—Dyspepsia—Risedronate—osteoporosis	3.11e-05	0.00131	CcSEcCtD
Etidronic acid—Constipation—Ethinyl Estradiol—osteoporosis	3.1e-05	0.0013	CcSEcCtD
Etidronic acid—Confusional state—Zoledronate—osteoporosis	3.09e-05	0.0013	CcSEcCtD
Etidronic acid—Hypersensitivity—Calcitriol—osteoporosis	3.09e-05	0.0013	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—TPI1—osteoporosis	3.09e-05	0.00508	CbGpPWpGaD
Etidronic acid—Arthralgia—Conjugated Estrogens—osteoporosis	3.08e-05	0.00129	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Pamidronate—osteoporosis	3.06e-05	0.00129	CcSEcCtD
Etidronic acid—Diarrhoea—Estropipate—osteoporosis	3.06e-05	0.00129	CcSEcCtD
Etidronic acid—Infection—Zoledronate—osteoporosis	3.05e-05	0.00128	CcSEcCtD
Etidronic acid—Pruritus—Ibandronate—osteoporosis	3.03e-05	0.00127	CcSEcCtD
Etidronic acid—Constipation—Risedronate—osteoporosis	3.02e-05	0.00127	CcSEcCtD
Etidronic acid—Paraesthesia—Pamidronate—osteoporosis	3.01e-05	0.00127	CcSEcCtD
Etidronic acid—Diarrhoea—Alendronate—osteoporosis	3.01e-05	0.00127	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—MGLL—osteoporosis	2.99e-05	0.00492	CbGpPWpGaD
Etidronic acid—Feeling abnormal—Ethinyl Estradiol—osteoporosis	2.98e-05	0.00125	CcSEcCtD
Etidronic acid—Pruritus—Calcitriol—osteoporosis	2.97e-05	0.00125	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	2.96e-05	0.00125	CcSEcCtD
Etidronic acid—Diarrhoea—Raloxifene—osteoporosis	2.96e-05	0.00125	CcSEcCtD
Etidronic acid—Dyspepsia—Pamidronate—osteoporosis	2.95e-05	0.00124	CcSEcCtD
Etidronic acid—Alopecia—Estradiol—osteoporosis	2.94e-05	0.00124	CcSEcCtD
Etidronic acid—Infection—Conjugated Estrogens—osteoporosis	2.93e-05	0.00123	CcSEcCtD
Etidronic acid—Diarrhoea—Ibandronate—osteoporosis	2.93e-05	0.00123	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—LRP5—osteoporosis	2.92e-05	0.00481	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—P4HB—osteoporosis	2.9e-05	0.00478	CbGpPWpGaD
Etidronic acid—Erythema—Estradiol—osteoporosis	2.89e-05	0.00122	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Risedronate—osteoporosis	2.89e-05	0.00121	CcSEcCtD
Etidronic acid—Urticaria—Ethinyl Estradiol—osteoporosis	2.88e-05	0.00121	CcSEcCtD
Etidronic acid—Constipation—Pamidronate—osteoporosis	2.87e-05	0.00121	CcSEcCtD
Etidronic acid—Diarrhoea—Calcitriol—osteoporosis	2.87e-05	0.00121	CcSEcCtD
Etidronic acid—Abdominal pain—Ethinyl Estradiol—osteoporosis	2.86e-05	0.0012	CcSEcCtD
Etidronic acid—Flatulence—Estradiol—osteoporosis	2.85e-05	0.0012	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—GAPDH—osteoporosis	2.85e-05	0.00469	CbGpPWpGaD
Etidronic acid—Vomiting—Estropipate—osteoporosis	2.84e-05	0.00119	CcSEcCtD
Etidronic acid—Rash—Estropipate—osteoporosis	2.82e-05	0.00118	CcSEcCtD
Etidronic acid—Dermatitis—Estropipate—osteoporosis	2.81e-05	0.00118	CcSEcCtD
Etidronic acid—Urticaria—Risedronate—osteoporosis	2.8e-05	0.00118	CcSEcCtD
Etidronic acid—Headache—Estropipate—osteoporosis	2.8e-05	0.00118	CcSEcCtD
Etidronic acid—Vomiting—Alendronate—osteoporosis	2.8e-05	0.00118	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Zoledronate—osteoporosis	2.79e-05	0.00117	CcSEcCtD
Etidronic acid—Abdominal pain—Risedronate—osteoporosis	2.79e-05	0.00117	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—LRP6—osteoporosis	2.79e-05	0.0046	CbGpPWpGaD
Etidronic acid—Muscle spasms—Estradiol—osteoporosis	2.78e-05	0.00117	CcSEcCtD
Etidronic acid—Rash—Alendronate—osteoporosis	2.77e-05	0.00117	CcSEcCtD
Etidronic acid—Dermatitis—Alendronate—osteoporosis	2.77e-05	0.00117	CcSEcCtD
Etidronic acid—Feeling abnormal—Pamidronate—osteoporosis	2.77e-05	0.00116	CcSEcCtD
Etidronic acid—Headache—Alendronate—osteoporosis	2.76e-05	0.00116	CcSEcCtD
Etidronic acid—Paraesthesia—Zoledronate—osteoporosis	2.75e-05	0.00116	CcSEcCtD
Etidronic acid—Vomiting—Raloxifene—osteoporosis	2.75e-05	0.00116	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Pamidronate—osteoporosis	2.74e-05	0.00115	CcSEcCtD
Etidronic acid—Rash—Raloxifene—osteoporosis	2.73e-05	0.00115	CcSEcCtD
Etidronic acid—Dermatitis—Raloxifene—osteoporosis	2.73e-05	0.00115	CcSEcCtD
Etidronic acid—Vomiting—Ibandronate—osteoporosis	2.72e-05	0.00115	CcSEcCtD
Etidronic acid—Headache—Raloxifene—osteoporosis	2.71e-05	0.00114	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—NFATC1—osteoporosis	2.71e-05	0.00446	CbGpPWpGaD
Etidronic acid—Rash—Ibandronate—osteoporosis	2.7e-05	0.00114	CcSEcCtD
Etidronic acid—Dermatitis—Ibandronate—osteoporosis	2.7e-05	0.00113	CcSEcCtD
Etidronic acid—Dyspepsia—Zoledronate—osteoporosis	2.7e-05	0.00113	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	2.69e-05	0.00113	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—DKK1—osteoporosis	2.68e-05	0.00442	CbGpPWpGaD
Etidronic acid—Headache—Ibandronate—osteoporosis	2.68e-05	0.00113	CcSEcCtD
Etidronic acid—Hypersensitivity—Ethinyl Estradiol—osteoporosis	2.67e-05	0.00112	CcSEcCtD
Etidronic acid—Vomiting—Calcitriol—osteoporosis	2.67e-05	0.00112	CcSEcCtD
Etidronic acid—Nausea—Estropipate—osteoporosis	2.65e-05	0.00112	CcSEcCtD
Etidronic acid—Abdominal pain—Pamidronate—osteoporosis	2.65e-05	0.00112	CcSEcCtD
Etidronic acid—Paraesthesia—Conjugated Estrogens—osteoporosis	2.65e-05	0.00111	CcSEcCtD
Etidronic acid—Angioedema—Estradiol—osteoporosis	2.65e-05	0.00111	CcSEcCtD
Etidronic acid—Rash—Calcitriol—osteoporosis	2.64e-05	0.00111	CcSEcCtD
Etidronic acid—Dermatitis—Calcitriol—osteoporosis	2.64e-05	0.00111	CcSEcCtD
Etidronic acid—Headache—Calcitriol—osteoporosis	2.63e-05	0.0011	CcSEcCtD
Etidronic acid—Constipation—Zoledronate—osteoporosis	2.62e-05	0.0011	CcSEcCtD
Etidronic acid—ATP6V1A—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.62e-05	0.00431	CbGpPWpGaD
Etidronic acid—Nausea—Alendronate—osteoporosis	2.61e-05	0.0011	CcSEcCtD
Etidronic acid—Hypersensitivity—Risedronate—osteoporosis	2.6e-05	0.00109	CcSEcCtD
Etidronic acid—Dyspepsia—Conjugated Estrogens—osteoporosis	2.6e-05	0.00109	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—WNT1—osteoporosis	2.59e-05	0.00426	CbGpPWpGaD
Etidronic acid—Nausea—Raloxifene—osteoporosis	2.57e-05	0.00108	CcSEcCtD
Etidronic acid—Pruritus—Ethinyl Estradiol—osteoporosis	2.56e-05	0.00108	CcSEcCtD
Etidronic acid—Nausea—Ibandronate—osteoporosis	2.54e-05	0.00107	CcSEcCtD
Etidronic acid—Feeling abnormal—Zoledronate—osteoporosis	2.53e-05	0.00106	CcSEcCtD
Etidronic acid—Constipation—Conjugated Estrogens—osteoporosis	2.52e-05	0.00106	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—FGA—osteoporosis	2.52e-05	0.00414	CbGpPWpGaD
Etidronic acid—Gastrointestinal pain—Zoledronate—osteoporosis	2.51e-05	0.00105	CcSEcCtD
Etidronic acid—Pruritus—Risedronate—osteoporosis	2.5e-05	0.00105	CcSEcCtD
Etidronic acid—Nausea—Calcitriol—osteoporosis	2.49e-05	0.00105	CcSEcCtD
Etidronic acid—Diarrhoea—Ethinyl Estradiol—osteoporosis	2.48e-05	0.00104	CcSEcCtD
Etidronic acid—Hypersensitivity—Pamidronate—osteoporosis	2.47e-05	0.00104	CcSEcCtD
Etidronic acid—Arthralgia—Estradiol—osteoporosis	2.46e-05	0.00104	CcSEcCtD
Etidronic acid—Urticaria—Zoledronate—osteoporosis	2.44e-05	0.00102	CcSEcCtD
Etidronic acid—Discomfort—Estradiol—osteoporosis	2.44e-05	0.00102	CcSEcCtD
Etidronic acid—Abdominal pain—Zoledronate—osteoporosis	2.42e-05	0.00102	CcSEcCtD
Etidronic acid—Diarrhoea—Risedronate—osteoporosis	2.42e-05	0.00102	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	2.41e-05	0.00102	CcSEcCtD
Etidronic acid—Confusional state—Estradiol—osteoporosis	2.38e-05	0.001	CcSEcCtD
Etidronic acid—Pruritus—Pamidronate—osteoporosis	2.37e-05	0.000999	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—TLN1—osteoporosis	2.36e-05	0.00388	CbGpPWpGaD
Etidronic acid—Infection—Estradiol—osteoporosis	2.35e-05	0.000987	CcSEcCtD
Etidronic acid—Urticaria—Conjugated Estrogens—osteoporosis	2.35e-05	0.000986	CcSEcCtD
Etidronic acid—Abdominal pain—Conjugated Estrogens—osteoporosis	2.33e-05	0.000981	CcSEcCtD
Etidronic acid—Vomiting—Ethinyl Estradiol—osteoporosis	2.3e-05	0.000968	CcSEcCtD
Etidronic acid—Diarrhoea—Pamidronate—osteoporosis	2.3e-05	0.000966	CcSEcCtD
Etidronic acid—Rash—Ethinyl Estradiol—osteoporosis	2.28e-05	0.00096	CcSEcCtD
Etidronic acid—Dermatitis—Ethinyl Estradiol—osteoporosis	2.28e-05	0.000959	CcSEcCtD
Etidronic acid—Headache—Ethinyl Estradiol—osteoporosis	2.27e-05	0.000954	CcSEcCtD
Etidronic acid—Hypersensitivity—Zoledronate—osteoporosis	2.26e-05	0.00095	CcSEcCtD
Etidronic acid—Vomiting—Risedronate—osteoporosis	2.24e-05	0.000944	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—ENO1—osteoporosis	2.24e-05	0.00369	CbGpPWpGaD
Etidronic acid—Rash—Risedronate—osteoporosis	2.23e-05	0.000936	CcSEcCtD
Etidronic acid—Dermatitis—Risedronate—osteoporosis	2.22e-05	0.000935	CcSEcCtD
Etidronic acid—Headache—Risedronate—osteoporosis	2.21e-05	0.00093	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—PSMA2—osteoporosis	2.21e-05	0.00364	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—PSMA5—osteoporosis	2.21e-05	0.00364	CbGpPWpGaD
Etidronic acid—Hypersensitivity—Conjugated Estrogens—osteoporosis	2.18e-05	0.000915	CcSEcCtD
Etidronic acid—Pruritus—Zoledronate—osteoporosis	2.17e-05	0.000912	CcSEcCtD
Etidronic acid—Musculoskeletal discomfort—Estradiol—osteoporosis	2.15e-05	0.000905	CcSEcCtD
Etidronic acid—Nausea—Ethinyl Estradiol—osteoporosis	2.15e-05	0.000905	CcSEcCtD
Etidronic acid—Vomiting—Pamidronate—osteoporosis	2.13e-05	0.000897	CcSEcCtD
Etidronic acid—Paraesthesia—Estradiol—osteoporosis	2.12e-05	0.000892	CcSEcCtD
Etidronic acid—Rash—Pamidronate—osteoporosis	2.12e-05	0.00089	CcSEcCtD
Etidronic acid—Dermatitis—Pamidronate—osteoporosis	2.11e-05	0.000889	CcSEcCtD
Etidronic acid—Headache—Pamidronate—osteoporosis	2.1e-05	0.000884	CcSEcCtD
Etidronic acid—Diarrhoea—Zoledronate—osteoporosis	2.1e-05	0.000882	CcSEcCtD
Etidronic acid—Nausea—Risedronate—osteoporosis	2.1e-05	0.000882	CcSEcCtD
Etidronic acid—Pruritus—Conjugated Estrogens—osteoporosis	2.09e-05	0.000878	CcSEcCtD
Etidronic acid—Dyspepsia—Estradiol—osteoporosis	2.08e-05	0.000875	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—CALCA—osteoporosis	2.06e-05	0.00339	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—P4HB—osteoporosis	2.03e-05	0.00335	CbGpPWpGaD
Etidronic acid—Constipation—Estradiol—osteoporosis	2.02e-05	0.00085	CcSEcCtD
Etidronic acid—Diarrhoea—Conjugated Estrogens—osteoporosis	2.02e-05	0.000849	CcSEcCtD
Etidronic acid—Nausea—Pamidronate—osteoporosis	1.99e-05	0.000838	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—PTH—osteoporosis	1.98e-05	0.00326	CbGpPWpGaD
Etidronic acid—Vomiting—Zoledronate—osteoporosis	1.95e-05	0.00082	CcSEcCtD
Etidronic acid—Feeling abnormal—Estradiol—osteoporosis	1.95e-05	0.000819	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—RAP1A—osteoporosis	1.94e-05	0.0032	CbGpPWpGaD
Etidronic acid—Rash—Zoledronate—osteoporosis	1.93e-05	0.000813	CcSEcCtD
Etidronic acid—Gastrointestinal pain—Estradiol—osteoporosis	1.93e-05	0.000812	CcSEcCtD
Etidronic acid—Dermatitis—Zoledronate—osteoporosis	1.93e-05	0.000812	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—CNR2—osteoporosis	1.93e-05	0.00317	CbGpPWpGaD
Etidronic acid—Headache—Zoledronate—osteoporosis	1.92e-05	0.000808	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—NFATC1—osteoporosis	1.89e-05	0.00312	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—DKK1—osteoporosis	1.88e-05	0.0031	CbGpPWpGaD
Etidronic acid—Vomiting—Conjugated Estrogens—osteoporosis	1.88e-05	0.000789	CcSEcCtD
Etidronic acid—Urticaria—Estradiol—osteoporosis	1.88e-05	0.000789	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—KL—osteoporosis	1.87e-05	0.00308	CbGpPWpGaD
Etidronic acid—Abdominal pain—Estradiol—osteoporosis	1.87e-05	0.000785	CcSEcCtD
Etidronic acid—Rash—Conjugated Estrogens—osteoporosis	1.86e-05	0.000783	CcSEcCtD
Etidronic acid—Dermatitis—Conjugated Estrogens—osteoporosis	1.86e-05	0.000782	CcSEcCtD
Etidronic acid—Headache—Conjugated Estrogens—osteoporosis	1.85e-05	0.000778	CcSEcCtD
Etidronic acid—Nausea—Zoledronate—osteoporosis	1.82e-05	0.000766	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—WNT1—osteoporosis	1.81e-05	0.00298	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—FGA—osteoporosis	1.76e-05	0.0029	CbGpPWpGaD
Etidronic acid—Nausea—Conjugated Estrogens—osteoporosis	1.75e-05	0.000737	CcSEcCtD
Etidronic acid—Hypersensitivity—Estradiol—osteoporosis	1.74e-05	0.000732	CcSEcCtD
Etidronic acid—Pruritus—Estradiol—osteoporosis	1.67e-05	0.000703	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—BMP2—osteoporosis	1.64e-05	0.0027	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PTHLH—osteoporosis	1.64e-05	0.0027	CbGpPWpGaD
Etidronic acid—Diarrhoea—Estradiol—osteoporosis	1.62e-05	0.00068	CcSEcCtD
Etidronic acid—ATP6V1A—Signaling Pathways—FGB—osteoporosis	1.6e-05	0.00264	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PSMA2—osteoporosis	1.55e-05	0.00255	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—PSMA5—osteoporosis	1.55e-05	0.00255	CbGpPWpGaD
Etidronic acid—Vomiting—Estradiol—osteoporosis	1.5e-05	0.000632	CcSEcCtD
Etidronic acid—Rash—Estradiol—osteoporosis	1.49e-05	0.000626	CcSEcCtD
Etidronic acid—Dermatitis—Estradiol—osteoporosis	1.49e-05	0.000626	CcSEcCtD
Etidronic acid—Headache—Estradiol—osteoporosis	1.48e-05	0.000622	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—ADCY5—osteoporosis	1.46e-05	0.00241	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—CALCA—osteoporosis	1.44e-05	0.00238	CbGpPWpGaD
Etidronic acid—Nausea—Estradiol—osteoporosis	1.4e-05	0.00059	CcSEcCtD
Etidronic acid—ATP6V1A—Disease—MTHFR—osteoporosis	1.35e-05	0.00222	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—KL—osteoporosis	1.31e-05	0.00216	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—IRS2—osteoporosis	1.28e-05	0.00211	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—IRS1—osteoporosis	1.12e-05	0.00184	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—IL6R—osteoporosis	1.05e-05	0.00173	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ADCY5—osteoporosis	1.03e-05	0.00169	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—SPP1—osteoporosis	9.92e-06	0.00163	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IRS2—osteoporosis	8.97e-06	0.00148	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—LEP—osteoporosis	8.78e-06	0.00145	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—ESR1—osteoporosis	8.38e-06	0.00138	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IRS1—osteoporosis	7.83e-06	0.00129	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—POMC—osteoporosis	7.54e-06	0.00124	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL6R—osteoporosis	7.36e-06	0.00121	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IGF1—osteoporosis	7.26e-06	0.0012	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—MYC—osteoporosis	6.23e-06	0.00103	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—TGFB1—osteoporosis	6.21e-06	0.00102	CbGpPWpGaD
Etidronic acid—ATP6V1A—Disease—IL6—osteoporosis	4.68e-06	0.000771	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—MYC—osteoporosis	4.36e-06	0.000718	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—TGFB1—osteoporosis	4.35e-06	0.000717	CbGpPWpGaD
Etidronic acid—ATP6V1A—Signaling Pathways—IL6—osteoporosis	3.28e-06	0.00054	CbGpPWpGaD
